CD40 and lipoprotein glomerulopathy: The aim of our study was to assess the level of anti-UCH-L1 antibodies and anti-CD40 antibodies as potential factors of podocyte damage in patients with different glomerulopathies, and to evaluate their significance in diagnosis of primary podocyte diseases.